March 30, 2026 7:40am

After markets and C&GT sector so down, they need an up in a holiday shortened week

The biggest question of the week: Is March the month where the Bureau of Labor Statistics' marquee nonfarm payrolls report goes back to results anywhere near estimates?

The only thing that matters now, is how long Iran is willing to choke off Persian Gulf oil, and how long the rest of the world will let it go on?

Never leave retail investor uninformed … I say what others won’t, so you can KNOW what others can’t!

 

 

Say/write less, mean more …

Friday’s RMi Closing Bell: Sector plunges even deeper in the hole … https://www.regmedinvestors.com/articles/14364

I chose to speak-up when many analysts, brokers and commentators have shut-up!

 

Remember that overnight action in futures don't necessarily translate into actual trading in today’s regular stock market session.

Monday: The pre-open Dow futures are UP +0.59% or (+263 points), the S&P futures are UP +0.58% or (+37 points) and the Nasdaq futures are UP +0.51% or (+115 pints)

  • U.S. stock futures creeped higher, Monday 3/30
  • European equities and bourses mixed and muted
  • Asia Pacific markets declined

Economic Data: It’s still all about oil pricing and Dallas Fed manufacturing (March) activity

The market will be closed on Friday in observance of Good Friday, although the March jobs report is still scheduled for release that morning. Investors will also be scrutinizing the Job Openings and Labor Turnover Survey (JOLTS) and the ADP Employment Survey due out earlier in the week.

  • 10:30 am             Federal Reserve Chair Jerome Powell speaks                                                      
  • 4:00 pm               New York Fed President John Williams speaks

 

Henry’omics: We need to more than consider the market’s setting to grasp the micro re “our” universe of cell and gene therapy companies

  • Friday: The Dow closed DOWN -793.47 points or -1.73%, the S&P closed DOWN -108.31 points or -1.67% while the Nasdaq closed DOWN -459.724 points or -2.15%
  • Thursday: The Dow closed DOWN -469.38 points or -1.01%, the S&P closed DOWN -114.74 points or -1.74% while the Nasdaq closed DOWN -521.744 points or -2.38%
  • Wednesday: The Dow closed UP +305.43 points or +0.66%, the S&P closed UP +35.53 points or +0.54% while the Nasdaq closed UP +167.931 points or +0.77%
  • Tuesday: The Dow closed DOWN -84.41 points or -0.18%, the S&P closed DOWN -24.63 points or -0.37% while the Nasdaq closed DOWN -184.865 points or -0.84%
  • Monday: The Dow closed UP +631.12 points or +1.38%, the S&P closed UP +74.52 points or +1.15% while the Nasdaq closed UP +299.149 points or +1.38%
  • Last week: the S&P sank -2%, the Dow fell -3% and the Nasdaq dived -1.59%
  • The previous week: the S&P 500 lost -1.5%, the Dow and Nasdaq fell around -2%
  • February: the Dow inclined +0.2%, the Nasdaq dived -3.3% and S&P 500 declined -1%.

 

Q1/26 – Q1 – March – 8 positive and 12 negative closes

  • February – 1 market holiday, 11 positive and 8 negative closes
  • January – 2 holiday, 2 neutral, 9 negative and 9 positive closes 

 

Companies in my headlights – It’s your decision; I provide ideas and context

I post about “indication intelligence” looking toward investment conferences … to assist investors with insight into sector vulnerabilities and strengths.  A dictionary definition of “indicate” refers to something less than a certainty; an indication could be a signal of being oversold or overbought, a recommendation, or grounds for inferring or a basis for believing.

  • Still not feeling the love, and if I did I wouldn’t trust it, a new high  that will be stropped right away

 

The BOTTOM LINE: Welcome to my world of defining the “grey’ in our universe!

My thoughts … HOLD, if BUYing – be very selective!

US stocks ended another week in the red as the war raging through the Gulf region rolls on with no end in sight and US equity markets keep falling.

  • The Nasdaq slid a steeper 2.2% on Friday for a year-to-date loss of roughly 10%.
  • Friday's jobs report from the Bureau of Labor Statistics will headline a busy economic calendar, with the central question for investors set to be whether payrolls numbers will normalize after the whiplash of 130,000 jobs added in January and 92,000 jobs lost in February.
  • Investors will also get reads on market sentiment and expectations from the Conference Board on Tuesday, as well as additional labor market reads from the JOLTS report on Tuesday and the outplacement firm Challenger, Gray & Christmas on Thursday.

 

Welcome to my world of defining the “grey’ in our universe!

  • I hate to be so negative or contrarian but, this is a NO spin zone and facts and truth are its products; I can always be WRONG but, I am mostly EARLY!
  • if I wanted to be liked, I wouldn’t have been an analyst/journalist.

 

March – 4th week:

  • 3/27 – Friday closed negative with 1 incliner, 36 decliners and 3 flats
  • 3/26 – Thursday closed negative with 15 incliner, 22 decliners and 3 flats
  • 3/25 – Wednesday closed positive with 30 incliners, 5 decliners and 5 flats
  • 3/24 – Tuesday closed negative with 11 incliner, 26 decliners and 3 flats
  • 3/23 - Monday closed positive with 26 incliners, 12 decliners and 2 flats

March – 3rd week

  • 3/20 – Friday closed negative with 6 incliner, 33 decliners and 1 flat
  • 3/19 – Thursday closed positive with 20 incliners, 18 decliners and 2 flats
  • 3/18 – Wednesday closed negative with 3 incliner, 35 decliners and 2 flats
  • 3/17 - Tuesday closed positive with 25 incliners, 14 decliners and 1 flat
  • 3/16 - Monday closed positive with 27 incliners, 10 decliners and 3 flats

 

As the leading voice of cell and gene therapy investors; I am NOT always a doom and gloom analyst/journalist but a man who has been “there” (BUY, SELL, VC and multiple operating roles) with the gray hair and a readership following with real numbers to prove it!

  • I am more frequently right than consequentially wrong; if I wanted to be liked, I wouldn’t have been an analyst/journalist.

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice. All investments are subject to risks. Investors should consider investment objectives.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.  Regulation Analyst Certification (Reg AC):

The research analyst primarily responsible for the content of this report certifies the following under Reg AC: I hereby certify that all views expressed in this report accurately reflect my personal views about the subject company or companies and it’s or their securities. I also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed.